🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In January 2024, Pharmac's waiting list includes drugs or devices to treat the following conditions: + schizophrenia + prostate cancer + Fabry disease + rheumatoid arthritis + bladder cancer + multiple myeloma + bowel cancer + Type 1 diabetes + breast cancer + lung cancer +

Insightful analysis from ⁦Fran O'Sullivan⁩ on whether James Shaw should leave the Greens. nzherald.co.nz/business/is-it…

Brilliant from Josie Pagani. A calm, intelligent, unifying approach to political communication. thepost.co.nz/nz-news/350164…

Yes, you are right. I am so sorry for your situation. The human cost and economic impact of Pharmac’s failings is growing. Daratumumab has been on the waiting list for years. It is funded widely around the world and is a life-enabling drug. I’ve been reporting on the importance

Just dropping in here to give a bouquet to Breast Screen Aotearoa. Had a publicly-funded mammogram this morning ✅ Such a brilliant, patient-centric, professional service. Fully staffed by immigrants. Everyone very happy the screening age has been raised to 74. You gotta look

The human cost of Pharmac's failings laid bare. This story is about a much-needed leukaemia drug and a young family advocating for care, but in the middle of the story the Director of the Leukaemia and Blood Foundation, Peter Browett, estimates that up to 15 people died waiting

Such terrible news for the talented team at Newshub. Cut my teeth at TV3 some 25 years ago and spent the majority of my career there. On so many occasions, TV3 set or shaped the news agenda, forced One News to deliver a better product, and was a much-needed voice for the

More superb reporting from @nickjonesnzer Pharmac remains stagnant and unresponsive on (another) cancer treatment which our peer nations consider the standard of care. Daratumumab is funded in 48 countries - but not here. It is unthinkable that we can continue like this.

This story is increasingly intriguing….

My Dad died of myeloma in 2016. Back then, I didn’t fully understand the function of Pharmac, and I hadn’t heard of a drug called Daratumumab. The following year, in 2017, Pharmac documented an application to fund Dara to treat myeloma. Seven years later, Dara sits dormant on

David Seymour puts his cards on the table in an interview with @nickjonesnzer at The Herald. The Minister outlines the Government's plans, and if they come to fruition we are on the precipice of genuine reform at Pharmac. + we now have direct political accountability with the

The great and the good that is ⁦Miriama Kamo⁩ delivering a confronting opening to ⁦Kiwibank New Zealander of the Year Awards⁩ ….”our differences are crucial to our national identity”.

The failings and delays that cause harm and impact mortality - a forensic look at how the Southern region’s cancer services failed a mother.

Succinct pre-Budget report from ⁦Jenna Lynch⁩ on our medicines crisis. What a mess we’re in. The waiting list is impacting more than 200k kiwis. Pharmac needs major reform, funding, and fresh leadership. newshub.co.nz/home/politics/…

There is some great journalism in this thread. If you can contribute, please connect with Georgina.

Zero money for cancer medicines. Zero. I don’t know what to say or how to process any of this. My phone is running hot with calls from patients and patient advocates and I can’t explain what’s just happened. I don’t have any answers. In October last year, patients voted on a

Steven Joyce, thank you. "The one significant blemish that may dog the Government is its inexplicable failure to make good on its cancer drugs promise. It seems weird that you can trumpet a massive $17b increase in health spending across three Budgets and yet not dedicate any of

Emmerson, too. So many are touched by cancer. This won’t go away.

Big story in Stuff this morning - a major funding uplift for Pharmac. Yet to be signed off by Cabinet, but Rachel Thomas is reporting a $600m funding increase to Pharmac for meds ($150m annually over 4 years). If confirmed, this will cover a chunk of Pharmac’s waiting list.